110 related articles for article (PubMed ID: 28456932)
1. Synergistic Activity for Natural and Synthetic Inhibitors of Angiogenesis Induced by Murine Sarcoma L-1 and Human Kidney Cancer Cells.
Bałan BJ; Siwicki AK; Pastewka K; Demkow U; Skopiński P; Skopińska-Różewska E; Lewicki S; Zdanowski R
Adv Exp Med Biol; 2017; 1020():91-104. PubMed ID: 28456932
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of shark liver oil on cutaneous angiogenesis induced in Balb/c mice by syngeneic sarcoma L-1, human urinary bladder and human kidney tumour cells.
Skopinska-Rózewska E; Krotkiewski M; Sommer E; Rogala E; Filewska M; Bialas-Chromiec B; Pastewka K; Skurzak H
Oncol Rep; 1999; 6(6):1341-4. PubMed ID: 10523708
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of herbal remedy PERVIVO and anti-inflammatory drug sulindac on L-1 sarcoma tumor growth and tumor angiogenesis in Balb/c mice.
Skopiński P; Bałan BJ; Kocik J; Zdanowski R; Lewicki S; Niemcewicz M; Gawrychowski K; Skopińska-Różewska E; Stankiewicz W
Mediators Inflamm; 2013; 2013():289789. PubMed ID: 23935247
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
Takahashi N; Haba A; Matsuno F; Seon BK
Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of Greenland shark liver oil combined with squalen and arctic birch ashes on angiogenesis and L-1 sarcoma growth in Balb/c mice.
Skopińska-Rózewska E; Chorostowska-Wynimko J; Krotkiewski M; Rogala E; Sommer E; Demkow U; Skurzak H
Pol J Vet Sci; 2003; 6(3 Suppl):54-6. PubMed ID: 14509365
[TBL] [Abstract][Full Text] [Related]
6. Adenosine receptor antagonism causes inhibition of angiogenic activity of human ovarian cancer cells.
Barcz E; Sommer E; Janik P; Marianowski L; Skopinska-Rózewska E
Oncol Rep; 2000; 7(6):1285-91. PubMed ID: 11032931
[TBL] [Abstract][Full Text] [Related]
7. A quantitative angiogenesis model for efficacy testing of chemopreventive agents.
Sharma S; Ghoddoussi M; Gao P; Kelloff GJ; Steele VE; Kopelovich L
Anticancer Res; 2001; 21(6A):3829-37. PubMed ID: 11911254
[TBL] [Abstract][Full Text] [Related]
8. Suppression of angiogenic activity of sera from diabetic patients with non-proliferative retinopathy by compounds of herbal origin and sulindac sulfone.
Skopinski P; Szaflik J; Duda-Król B; Nartowska J; Sommer E; Chorostowska-Wynimko J; Demkow U; Skopinska-Rózewska E
Int J Mol Med; 2004 Oct; 14(4):707-11. PubMed ID: 15375605
[TBL] [Abstract][Full Text] [Related]
9. The effect of pentoxifylline on L-1 sarcoma tumor growth and angiogenesis in Balb/c mice.
Bałan BJ; Demkow U; Skopiński P; Bychawska M; Skopińska-Różewska E; Lewicki S; Zdanowski R
Cent Eur J Immunol; 2017; 42(2):131-139. PubMed ID: 28860931
[TBL] [Abstract][Full Text] [Related]
10. A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib.
Özcetin A; Aigner A; Bakowsky U
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):711-5. PubMed ID: 23891770
[TBL] [Abstract][Full Text] [Related]
11. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
Li X; Wang X; Ye H; Peng A; Chen L
Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
[TBL] [Abstract][Full Text] [Related]
12. Natural alkylglycerols restrain growth and metastasis of grafted tumors in mice.
Pedrono F; Martin B; Leduc C; Le Lan J; Saïag B; Legrand P; Moulinoux JP; Legrand AB
Nutr Cancer; 2004; 48(1):64-9. PubMed ID: 15203379
[TBL] [Abstract][Full Text] [Related]
13. Screening of angiogenesis inhibitors by modified tumor-induced angiogenesis (TIA) test in lung cancer.
Skopińska-Rózewska E; Sommer E; Demkow U; Chorostowska-Wynimko J; Bałan B; Rózycka B; Barcz E; Filewska M; Mlekodaj S; Rudziński P; Seweryniak W; Caban P; Kupis W; Bogdan J; Usiekniewicz P; Gatarek J; Langfort R
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():287-96. PubMed ID: 9337546
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional anti-angiogenic activity of the cyclic peroxide ANO-2 with antitumor activity.
Arakawa K; Endo Y; Kimura M; Yoshida T; Kitaoka T; Inakazu T; Nonami Y; Abe M; Masuyama A; Nojima M; Sasaki T
Int J Cancer; 2002 Jul; 100(2):220-7. PubMed ID: 12115573
[TBL] [Abstract][Full Text] [Related]
15. Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies.
Guyot M; Hilmi C; Ambrosetti D; Merlano M; Lo Nigro C; Durivault J; Grépin R; Pagès G
Oncotarget; 2017 Feb; 8(6):9174-9188. PubMed ID: 27999187
[TBL] [Abstract][Full Text] [Related]
16. Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model.
Drevs J; Hofmann I; Hugenschmidt H; Wittig C; Madjar H; Müller M; Wood J; Martiny-Baron G; Unger C; Marmé D
Cancer Res; 2000 Sep; 60(17):4819-24. PubMed ID: 10987292
[TBL] [Abstract][Full Text] [Related]
17. Role of Sulindac and Celecoxib in the regulation of angiogenesis during the early neoplasm of colon: exploring PI3-K/PTEN/Akt pathway to the canonical Wnt/β-catenin signaling.
Vaish V; Sanyal SN
Biomed Pharmacother; 2012 Jul; 66(5):354-67. PubMed ID: 22397759
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological blockade of cholesterol trafficking by cepharanthine in endothelial cells suppresses angiogenesis and tumor growth.
Lyu J; Yang EJ; Head SA; Ai N; Zhang B; Wu C; Li RJ; Liu Y; Yang C; Dang Y; Kwon HJ; Ge W; Liu JO; Shim JS
Cancer Lett; 2017 Nov; 409():91-103. PubMed ID: 28923401
[TBL] [Abstract][Full Text] [Related]
19. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of angiogenesis by sulindac and its sulfone metabolite (FGN-1): a potential mechanism for their antineoplastic properties.
Skopińska-Rózewska E; Piazza GA; Sommer E; Pamukcu R; Barcz E; Filewska M; Kupis W; Caban R; Rudziński P; Bogdan J; Mlekodaj S; Sikorska E
Int J Tissue React; 1998; 20(3):85-9. PubMed ID: 9894180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
